聚ADP核糖聚合酶
化学
DNA
体外
突变体
DNA修复
分子生物学
PARP抑制剂
DNA损伤
聚合酶
立体化学
生物化学
基因
生物
作者
Junkang Ren,Quan Xu,Ying Liu,Jiani Li,Xiaoyu Zhang,Zhiyu Li,Xiaomeng Zhang
标识
DOI:10.1016/j.bmcl.2022.129046
摘要
Inhibition of poly (ADP-ribose) polymerase (PARP) has been applied with great success in the clinical treatment of homologous recombination-deficient malignancy. Recent study demonstrated that not only PARP-1 inhibition but also DNA trapping contributes to the efficacy in BRCA mutant tumors and the toxicities results from the poor selectivity of PARP-1 over PARP-2 as well as their DNA trapping. Herein, a series of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives (7a-7l, 8a-8n) were synthesized and identified as PARP-1 selective inhibitors and PARP-1 DNA trappers. Among them, compound 8m was found to be highly potent and selective. It inhibited PARP-1 activity and BRCA mutant DLD-1 cell activity with IC50 values of 0.49 nM and 4.82 nM, and the in vitro DNA trapping efficacy of compound 8m was 1.85 nM. Compared with AZD5305, compound 8m significantly improved the selectivity of PARP-1 over PARP-2 as well. Compound 8m was>1000-fold selective for PARP-1 DNA trapping over PARP-2.
科研通智能强力驱动
Strongly Powered by AbleSci AI